These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25416367)

  • 1. Induced pluripotent stem cell-derived models for mtDNA diseases.
    Hämäläinen RH
    Methods Enzymol; 2014; 547():399-415. PubMed ID: 25416367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Characterization of Induced Pluripotent Stem Cells from Patients with mtDNA Mutations.
    Hämäläinen RH; Suomalainen A
    Methods Mol Biol; 2016; 1353():65-75. PubMed ID: 26187202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells (iPSCs) for modeling mitochondrial DNA disorders.
    Prigione A
    Methods Mol Biol; 2015; 1265():349-56. PubMed ID: 25634286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome.
    Finsterer J; Scorza FA; Scorza CA
    Med Arch; 2018 Jun; 72(3):234-236. PubMed ID: 30061775
    [No Abstract]   [Full Text] [Related]  

  • 5. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells with a mitochondrial DNA deletion.
    Cherry AB; Gagne KE; McLoughlin EM; Baccei A; Gorman B; Hartung O; Miller JD; Zhang J; Zon RL; Ince TA; Neufeld EJ; Lerou PH; Fleming MD; Daley GQ; Agarwal S
    Stem Cells; 2013 Jul; 31(7):1287-97. PubMed ID: 23400930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primigravida with very-long-chain acyl-CoA dehydrogenase deficiency.
    Murata KY; Sugie H; Nishino I; Kondo T; Ito H
    Muscle Nerve; 2014 Feb; 49(2):295-6. PubMed ID: 23966064
    [No Abstract]   [Full Text] [Related]  

  • 9. Two Novel Missense Mutations in Very Long Chain Acyl-CoA Dehydrogenase Deficiency.
    Yang B; Wang F
    Indian Pediatr; 2018 Mar; 55(3):261-262. PubMed ID: 29629707
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice.
    Katada S; Mito T; Ogasawara E; Hayashi J; Nakada K
    G3 (Bethesda); 2013 Sep; 3(9):1545-52. PubMed ID: 23853091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 5.712 kb mitochondrial DNA deletion in a patient with Pearson syndrome: a case report.
    Park J; Ryu H; Jang W; Chae H; Kim M; Kim Y; Kim J; Lee JW; Chung NG; Cho B; Suh BK
    Mol Med Rep; 2015 May; 11(5):3741-5. PubMed ID: 25543536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlinopathy and very-long-chain acyl coenzyme A dehydrogenase deficiency segregating in the same family.
    Aharoni S; Sadeh M; Silver EL; Straussberg R
    Isr Med Assoc J; 2011 Oct; 13(10):632-4. PubMed ID: 22097235
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.
    Chen XY; Zhao SY; Wang Y; Wang D; Dong CH; Yang Y; Wang ZH; Wu YM
    Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Jul; 27(4):2492-5. PubMed ID: 26016877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sideroblastic anemia associated with multisystem mitochondrial disorders.
    Tesarova M; Vondrackova A; Stufkova H; Veprekova L; Stranecky V; Berankova K; Hansikova H; Magner M; Galoova N; Honzik T; Vodickova E; Stary J; Zeman J
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27591. PubMed ID: 30588737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pearson syndrome in a Diamond-Blackfan anemia cohort.
    Alter BP
    Blood; 2014 Jul; 124(3):312-3. PubMed ID: 25035146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.
    Inak G; Lorenz C; Lisowski P; Zink A; Mlody B; Prigione A
    Stem Cells; 2017 Jul; 35(7):1655-1662. PubMed ID: 28544378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.